{{DISPLAYTITLE:''N''-Ethylnorketamine}}
{{Drugbox
| drug_name = ''N''-Ethylnorketamine
| IUPAC_name = 2-(2-Chlorophenyl)-2-(ethylamino)cyclohexan-1-one
| image = N-Ethylnorketamine_structure.png
| width = 200

<!--Clinical data-->
| tradename =  
| legal_status = 
| legal_CA = Schedule I
| legal_UK = Class B

<!--Identifiers-->
| CAS_number = 1354634-10-8
| ATC_prefix = none
| PubChem = 57483649
| ChemSpiderID = 35805667

<!--Chemical data-->
| C=14 | H=18 | Cl=1 | N=1 | O=1 
| molecular_weight = 251.751 g/mol
| smiles = Clc2ccccc2C1(NCC)CCCCC1=O
| StdInChI = 1S/C14H18ClNO/c1-2-16-14(10-6-5-9-13(14)17)11-7-3-4-8-12(11)15/h3-4,7-8,16H,2,5-6,9-10H2,1H3
| StdInChIKey = ITBBBZIIFJJMDU-UHFFFAOYSA-N
}}

'''''N''-Ethylnorketamine''' ('''ethketamine''', '''NENK''', '''2-Cl-2'-Oxo-PCE''') is a [[designer drug]] which is presumed to have similar properties to [[ketamine]], a [[Dissociative drug|dissociative]] [[anesthesia|anesthetic]] drug with [[hallucinogen]]ic and [[sedative]] effects. It has been sold over the internet since around September 2012, and identified in seized drug samples by analytical laboratories in the UK and other European countries.<ref>[http://www.homeoffice.gov.uk/publications/agencies-public-bodies/acmd1/methoxetamine2012?view=Binary Advisory Council on the Misuse of Drugs (ACMD) Methoxetamine Report (2012)]</ref>

==Legal Status==

As of October 2015 NENK is a controlled substance in the United Kingdom,<ref>[http://www.legislation.gov.uk/ukdsi/2013/9780111532980/pdfs/ukdsiem_9780111532980_en.pdf Explanatory Memorandum to the Misuse of Drugs (1971) Amendment Order 2013]</ref> China,<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref> and the US state of Alabama.<ref>{{cite web | url=https://legiscan.com/AL/text/SB333/2014 | title=Alabama Senate Bill 333 - Controlled substances, Schedule I, additional synthetic controlled substances and analogue substances included in, trafficking in controlled substance analogues, requisite weight increased, Secs. 13A-12-231, 20-2-23 am'd. | date=March 2014 | accessdate=28 September 2015}}</ref>

==References==
{{Reflist}}


{{Hallucinogens}}
{{Glutamate receptor modulators}}

{{DEFAULTSORT:Ethylnorketamine, N-}}

[[Category:Chloroarenes]]
[[Category:Designer drugs]]
[[Category:Dissociative drugs]]
[[Category:Euphoriants]]


{{hallucinogen-stub}}